Case Control Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jan 14, 2022; 28(2): 230-241
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.230
Table 1 Characteristics of the study population

Cases, n = 110
Controls, n = 252

n
Percent
n
Percent
Agea
mean63.212.754.511.8
Raceb
White10296.218685.7
Non-White43.83114.3
Sexa
Female9486.217669.8
Male1513.87630.2
Marital status
Married7570.814666.7
Not married3129.37333.3
Educationa
Less than college3634.012255.7
College or postgrad7066.09744.3
Cigarette smokingc
Never smoker4845.310748.9
Former smoker4643.46630.1
Current smoker1211.34621.0
Irritable bowel syndromeb
Yes1413.66028.0
No8986.415472.0
Table 2 Body mass index and risk of microscopic colitis

Cases
Controls



n = 101
n = 238
Crude
Adjusted1
BMI
n
%
n
%
OR (95%CI)
aOR (95%CI)
Overall
< 255049.57330.7Ref.Ref.
25 < 302928.76025.20.71 (0.40-1.25)0.70 (0.37-1.31)
≥ 302221.810544.10.31 (0.17-0.55)0.35 (0.18-0.66)
Women
< 254753.44728.7Ref.Ref.
25 -302427.33420.70.71 (0.36-1.37)0.67 (0.32-1.40)
≥ 301719.38350.60.20 (0.10-0.40)0.21 (0.10-0.45)
Men
< 25323.12635.1Ref.Ref.
25 -30538.52635.11.67 (0.36-7.71)2.22 (0.41-12.05)
≥ 30538.52229.71.97 (0.42-9.19)2.92 (0.52-16.22)
Lost weight
< 253460.73244.4Ref.Ref.
25 -301323.21723.60.72 (0.30-1.71)0.89 (0.35-2.22)
≥ 30916.12331.90.37 (0.15-0.91)0.49 (0.19-1.28)
No weight loss
< 251031.32019.4Ref.Ref.
25 -301340.63029.10.87 (0.31-2.36)0.64 (0.20-2.04)
≥ 30928.15351.50.33 (0.12-0.96)0.33 (0.10-1.11)
IBS
< 25969.21525.4Ref.Ref.
25-30215.41525.40.22 (0.04-1.21)0.26 (0.04-1.50)
≥ 30215.42949.20.11 (0.02-0.60)0.13 (0.02-0.76)
No IBS
< 253947.64732.6Ref.Ref.
25 -302631.73725.70.85 (0.44-1.63)0.78 (0.39-1.58)
≥ 301720.76041.70.34 (0.17-0.68)0.38 (0.18-0.79)
Table 3 Reproductive factors and risk of microscopic colitis in women

Cases
Controls




n = 94
n = 176
Crude
Model 11
Model 22

n
%
n
%
OR (95%CI)
aOR (95%CI)
aOR (95%CI)
Age of menarche
≤ 111820.54630.3Ref.Ref.Ref.
122427.33623.71.70 (0.80-3.61)1.30 (0.53-3.17)1.41 0.52-3.83)
132326.13825.01.55 (0.73-3.28)0.76 (0.31-1.85)0.54 (0.20-1.43)
≥ 142326.13221.11.84 (0.86-3.94)0.90 (0.36-2.28)0.85 (0.30-2.42)
Parity
Nulliparous1516.52919.0Ref.Ref.Ref.3
Parous7683.512481.11.04 (0.88-1.24)1.02 (0.83-1.25)1.00 (0.81-1.23)
Number of live births
None1516.52919.0Ref.Ref.Ref.3
11314.32013.11.26 (0.49-3.20)1.16 (0.39-3.48)1.19 (0.40-3.60)
24246.26039.21.35 (0.65-2.83)1.20 (0.50-2.89)1.15 (0.47-2.81)
3 or more2123.14428.80.92 (0.41-2.08)0.78 (0.28-2.16)0.83-0.30-2.35)
Age of first live birth (among parous women)
≤ 191317.13225.8Ref.Ref.Ref.
20-231215.84233.90.70 (0.28-1.75)0.24 (0.07-0.82)0.23 (0.07-0.85)
24-292634.22721.82.37 (1.02-5.49)0.76 (0.24-2.43)0.78 (0.23-2.63)
30+2532.92318.62.68 (1.13-6.31)1.07 (0.32-3.58)1.02 (0.28-3.68)
Oral contraceptives
No2729.72315.0Ref.Ref.Ref.
Yes6470.313085.00.42 (0.22-0.79)0.38 (0.17-0.84)0.20 (0.08-0.52)
Table 4 Menopausal factors and risk of microscopic colitis in women

Cases
Controls



n = 94
n = 176
Crude
Adjusted

n
%
n
%
OR (95%CI)
OR (95%CI)1
Menopausal status
Pre-menopausal1314.44026.1Ref.Ref.
Post-menopausal7785.611373.92.10 (1.05-4.18)1.20 (0.45-3.20)
Age at menopause
< 451724.34945.80.37 (0.19-0.74)0.64 (0.28-1.46)
45-544361.44643.0Ref.Ref.
55+1014.31211.20.89 (0.35-2.27)079 (0.28-2.22)
Menopausal type
Surgical3140.37062.0Ref.Ref.
Natural menopause46 59.74338.10.41 (0.23-0.75)0.76 (0.37-1.54)
Menopausal hormones2
No4660.59081.1Ref.Ref.
Ever3039.52118.92.80 (1.44-5.41)1.63 (0.73-3.62)
Years Postmenopausal hormones2
None4660.59081.8Ref.Ref.
1-7 yr1519.711102.67 (1.13-6.28)1.65 (0.59-4.65)
9+ yr1519.798.23.26 (1.33-8.02)1.68 (0.60-4.73)